The first-line treatment for acute management of deep venous thrombosis is unfractionated or low-molecular weight heparin. The MOA of heparin is binding to and potentiation of the action of antithrombin III. (FA2020 p671, p436)
submitted by โcassdawg(1781)
The first-line treatment for acute management of deep venous thrombosis is unfractionated or low-molecular weight heparin. The MOA of heparin is binding to and potentiation of the action of antithrombin III. (FA2020 p671, p436)